MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0778
+0.0008 (0.97%)
At close: Dec 9, 2025
MariMed Revenue
MariMed had revenue of $40.76M in the quarter ending September 30, 2025, with 0.42% growth. This brings the company's revenue in the last twelve months to $157.38M, down -0.18% year-over-year. In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth.
Revenue (ttm)
157.38M
Revenue Growth
-0.18%
P/S Ratio
0.20
Revenue / Employee
203.33K
Employees
832
Market Cap
30.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 157.96M | 9.37M | 6.30% |
| Dec 31, 2023 | 148.60M | 14.59M | 10.89% |
| Dec 31, 2022 | 134.01M | 12.55M | 10.33% |
| Dec 31, 2021 | 121.46M | 70.57M | 138.66% |
| Dec 31, 2020 | 50.90M | 5.29M | 11.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
| Northwest Biotherapeutics | 937.00K |
MariMed News
- 1 day ago - Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries - GlobeNewsWire
- 21 days ago - MariMed (MRMD) Launches Limited-Edition Winter Chews - GuruFocus
- 21 days ago - MariMed's Betty's Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's - GlobeNewsWire
- 4 weeks ago - MariMed GAAP EPS of -$0.01, revenue of $40.76M misses by $1.39M - Seeking Alpha
- 4 weeks ago - MariMed outlines national brand expansion and hemp entry while maintaining positive cash flow - Seeking Alpha
- 4 weeks ago - MariMed Inc. (MRMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - MariMed Inc (MRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry Challenges - GuruFocus
- 4 weeks ago - Q3 2025 MariMed Inc Earnings Call Transcript - GuruFocus